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The impact of abnormal placental karyotype on the inflammatory response within the villous tissue and peripheral circulation of
women with miscarriage was evaluated. Villous (n = 38) and venous blood samples (n = 26) were obtained from women with
missed miscarriage. Tissue chromosome analysis indicated 23 abnormal and 15 normal karyotypes. Concentration of tumour
necrosis factor alpha (TNFα), TNF-R1 and TNF-R2, and interleukin (IL)-10 were measured using flowcytometric bead array
in fresh villous homogenate, cultured villous extracts, culture medium, maternal whole blood, and plasma. Plasma TNFα/IL-
10 ratios were significantly (P < 0.05) lower in miscarriages with abnormal karyotype. In the abnormal karyotype group, there
were significantly higher levels of TNFα (P < 0.01), IL-10 (P < 0.01), TNF-R1 (P < 0.001), and TNF-R2 (P < 0.001) in the villous
extracts and culture-conditioned medium compared to normal karyotype group. In miscarriage with abnormal karyotype, there is
an exacerbated placental inflammatory response, in contrast to miscarriage of normal karyotype where maternal systemic response
is increased.
1. Introduction
Early pregnancy loss is the most common pregnancy com-
plication [1]. Around 60% of first trimester miscarriages
are associated with a chromosomal abnormality [2–4]. Most
chromosomal abnormalities are associated with primary
abnormal trophoblast invasion of the uterine decidua [5–
7]. As the placental development becomes increasingly
dependent on fetal synthesis towards the end of the first
trimester, isolated major fetal structural defects leading to
early fetal demise can also lead to secondary placental
dysfunction causing a miscarriage [8].
Inflammatory processes taking place at the feto-maternal
interface are essential for normal implantation in human
pregnancy [9–11]. It has been suggested that the main
regulator of this inflammatory reaction could be uterine
natural killer (NK) cells [10]. Proinflammatory cytokines
like tumour necrosis factor alpha (TNFα) have been shown
to inhibit trophoblast migration through the elevation of
plasminogen activator inhibitor-1 in first trimester villous
explant cultures, causing abnormal trophoblast invasion
[12]. TNFα has also been shown to downregulate the
endocrine function of trophoblasts, leading to pregnancy
failure [13]. It has been suggested that a network might
exist in which hormones together with cytokines regulate
the decidual expression of HLA-G, an antigen preferentially
expressed by trophoblast, thus, maintaining maternal-fetal
tolerance [14].
There is evidence of a shift in T-helper 1 (TNFα): T-
helper 2 (interleukin, IL-10) ratio in the maternal circulation
and placental villous tissue in first trimester miscarriages
[15–17]. However, most previous studies have used placental
tissue for early pregnancy failure without knowledge of
the karyotype or have focused on women presenting with
recurrent miscarriage, and thus little is known about the
impact of the conceptus karyotype on the placental and
systemic inflammatory responses in early pregnancy failure.
The aim of this study was therefore to investigate the
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maternal circulatory levels, villous expression, and secretion
in vitro of TNFα, TNFα receptors, and IL-10 and to evaluate
the Th1 and Th2 cytokine ratio in early pregnancy failures
with and without a chromosomal abnormality.
2. Materials and Methods
Chorionic villous samples (n = 38) were obtained from
women presenting with a missed miscarriage, undergoing
the evacuation of retained products of conception (ERPC)
at University College London Hospital (UCLH). All women
were nonsmokers, with normal body mass index (BMI)
ranging between 20 and 30, not on medication, and with
a history of regular menstrual cycles. The date of the last
menstrual period (LMP) was used to calculate the gestational
age, and women with a history of recurrent miscarriage or
who did not know their LMP were excluded from the study.
The gestational ages at the time of ERPC ranged between
9 weeks and 0 days and 13 weeks and 6 days gestation.
Ultrasound measurement of the fetal crown-rump length
(CRL) was used to evaluate the time interval between fetal
demise and the surgical procedure of ERPC.
In 12 cases with normal karyotype and 14 with abnormal
karyotype, maternal peripheral venous blood (10mL) was
collected by sterile venepuncture into bottles with lithium
heparin at the time of ERPC. One mL of uncoagulated blood
was aspirated aseptically for whole blood analysis while the
rest was centrifuged within 2 hours of collection, and the
plasma supernatant was stored at −80◦C until assayed.
This study was approved by the joint UCL/UCLH
ethics committee on the ethics of human research. Written
informed consent was obtained from each participant at the
Early Pregnancy Unit prior to the surgical uterine evacuation
of retained products of conception (ERPC).
2.1. Flowcytometric Analysis of Fluorescent Antibody-Labelled
Whole Blood. Initial whole blood validation experiments
showed that an incubation period of 12 hours with 40 ng/mL
of lipopolysaccharide (40 LPS) gave the highest increment
above basal level (0 LPS) in terms of cytokine expression by
the activated viable monocytes. Dual antibody labelling was
carried out with specific mouse antihuman antibodies (AbD
Serotec, Oxford, UK) that were conjugated to spectrally
distinct fluorochromes to identify the monocyte population
(CD14) positive for the cytokine/receptor of interest. The
method we used has been described elsewhere [18].
2.2. In Vitro Cultures. Following the ERPC, the placental
villi were separated from the rest of the POC and washed
twice in sterile Hank’s Balanced Salt Solution with 0.1%
Gentamycin Solution (Sigma-Aldrich, St Louis, USA) and
1% Amphotericin B (Invitrogen, Paisley, UK) to remove
any blood. A biopsy of villous tissue measuring ∼1 cm3 was
snap frozen in liquid nitrogen and stored at −80◦C until
homogenised to measure the cytokine/receptor content in
the villous tissue on the day of evacuation (Day 0). In all
cases, a villous sample was sent to a commercial cytogenetic
laboratory (TDL, London, UK) within 2 hours of the
ERPC, and karyotyping was carried out by standard cultur-
ing, suspension harvest and G-band analysis methodology
[19].
Villous tissue obtained from the ERPC was divided into
equal sections under sterile conditions under a laminar
hood and weighed. Each of the villous biopsies of known
weight was cultured in 24-well culture plates containing
1mL culture medium per well, in triplicate wells. Villous
explants derived from each individual woman were cultured
separately for 3 days at 6% and at 20% oxygen (O2)
levels in a moist incubator at 37◦C, 5% CO2. The culture
medium was made up of D-MEM: F-12 (1 : 1) + GlutaMAX-
I (Invitrogen, Paisley, UK) with 0.1% Gentamycin Solution
(Sigma-Aldrich, St Louis, USA) and 1% Amphotericin
and 1% Insulin-Transferrin-Selenium A serum supplement
(Invitrogen, Paisley, UK).
Villous explant culture conditioned medium and placen-
tal villi were collected after incubation for 1 day, 2 days, and
3 days from the individual wells. Cultured villous explants
were homogenized for cytokine analysis. Homogenization
of villous tissue was carried out as previously described
by our group [20]. All cytokines/receptors concentrations
in villous explants homogenates and culture-conditioned
medium were normalized against weight of tissue/well as
pg/gram villous tissue.
2.3. Cytokine and Receptor Assays. Cytokines and receptors
in plasma, culture medium, and homogenised villi were
measured using BD Cytometric Bead Array (CBA) Human
Soluble Protein Flex Sets and BD FACSArray bioana-
lyzer flowcytometer following manufacturer’s instructions
(BD Biosciences, San Jose, California, USA). The limit of
detection was 0.7 pg/mL for TNFα, 0.13 pg/mL for IL-10,
5.2 pg/mL for TNF-R1, and 1.4 pg/mL for TNF-R2. The
intra-assay coefficient of variation was 10.2% for TNFα, 6.4%
for IL-10, 2.6% for TNF-R1, and 7.1% for TNF-R2. The
interassay coefficient of variation was 5% for TNFα, 11% for
IL-10, 10.1% for TNF-R1, and 5.6% for TNF-R2. The results
were presented in graphical and tabular formats using the
FCAP Array Software (BD Biosciences, San Jose, Calif, USA).
2.4. Statistical Analysis. For villous cytokine expression and
the time- and O2-dependent villous explant medium con-
centrations, the data were log transformed to achieve norma-
lity, which was confirmed using the Shapiro-Wilks test and
Q-Q plots. Outliers were identified using Cook’s distance,
and those exceeding the threshold 4/n were removed.
For villous in vivo cytokine expression, ANOVA was
performed on the log-transformed data, to estimate means
for each cytokine by karyotype, adjusted for gestation at sam-
pling. Multivariate linear regressions were carried out on
the log-transformed data, to estimate the means for each
cytokine by karyotype, O2 level (6 versus 20%), and day
of culture (Day 1, 2, or 3), adjusted for gestation. For
cytokine/receptor levels in the plasma and monocytes, data
were normalized by log transformation, and unpaired t-test
was carried out.
A P-value less than 0.05 was considered statistically
significant. The statistical analysis and graphs were produced
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Table 1: In vivo cytokine and receptors, measured in snap frozen villous tissue collected on the day of ERPC—comparison done using 2-way
ANOVA, using the variables of karyotype (normal versus abnormal) and gestation (weeks). There was no significant difference between
gestation and karyotype. Estimated marginal means for each marker by karyotype, adjusted for gestation, are presented here.
Cytokine/receptor
Normal karyotype
pg/g (95% CI)
Abnormal karyotype
pg/g (95% CI)
Normal versus abnormal
karyotype
P value
TNFα 8.2 (5.3, 12.6) 7.2 (4.2, 12.2) 0.92
IL-10 2.2 (1.3, 3.8) 2.9 (1.6, 5.2) 0.79
TNFα/IL-10 4.5 (2.2, 9.0) 2.3 (1.3, 4.2) 0.62
TNF-R1 2499.1 (1488.8, 4195.3) 2753.26 (1927.21, 3933.4) 0.56
TNF-R2 12440.9 (6876.6, 22507.7) 12157.9 (8716.9, 16957.2) 0.68
Abnormal karyotype Normal karyotype
0
1
2
3
4
5 TNFα/IL10 in maternal plasma
Figure 1: TNFα/IL-10 in the maternal circulation (abnormal
karyotype, n = 14; normal karyotype, n = 12). There was a
significantly (P < 0.05) lower TNFα/IL-10 ratio in the plasma
of miscarriages of abnormal karyotype than in those with normal
karyotype.
using SPSS v.17 (SPSS Inc., Chicago, Ill, USA) and GraphPad
Prism v.5 (GraphPad Software inc., San Diego, Calif, USA).
3. Results
Karyotyping of the products of conception (POC) indicated
15 with normal karyotype and 23 abnormal karyotypes
including 16 trisomies, 4 monosomy X, and 3 triploidies.
There was no difference in maternal BMI, age, parity, and
ethnic distribution between the group with and without
a chromosomal abnormality. The gestation at the time of
ERPC, interval in days between estimated fetal demise and
ERPC and fetal sex ratio was similar in both groups. In
the cases where maternal blood was collected, karyotyping
showed 12 normal karyotypes and 14 abnormal karyotypes.
3.1. Maternal Plasma Concentrations. The levels of TNFα,
TNF-R1, TNF-R2, and IL-10 were not significantly different
between miscarriages with normal and abnormal karyotype.
TNFα/IL-10 ratio in the plasma was significantly (P < 0.05)
lower inmiscarriages with an abnormal karyotype than those
with normal karyotype (Figure 1).
3.2. Maternal Circulatory Monocyte Concentration. There
was no significant difference between intracellular levels of
TNFα, TNF-R1, TNF-R2, and IL-10 in the monocytes in
plasma samples of both groups. There was a 3-fold higher %
LPS stimulation of TNFα in the normal karyotype compared
to the abnormal karyotype group (Figures 2 and 3).
3.3. Expression of Cytokine and Receptors in Villous Tissue.
No significant differences were found in the cytokine and
receptor levels in the snap frozen villous tissue homogenate
samples between the groups presenting with normal and
abnormal karyotype. These levels were similar in the differ-
ent gestational subgroups, and across gestation (Table 1).
3.4. Villous Tissue In Vitro Secretion and Content of Cytokines
and Receptors. The ANOVA test indicated that gestation
has no significant impact on the relationship between
cytokine/receptor levels and karyotype in culture conditions
at both O2 concentrations.
Time in culture (1, 2, or 3 days) and O2 concentration
(6 versus 20%) did not affect the mean cytokine/receptor
levels or TNFα/IL-10 ratio in villous homogenates or culture-
conditioned medium adjusted for gestation (Table 2).
3.4.1. Villous Tissue Homogenates. Significantly higher levels
of TNFα (P < 0.01), IL-10 (P < 0.001), and TNF-R2 (P <
0.001 were found in cultured villous extracts in the group
with an abnormal karyotype compared to normal karyotype
group. There was no significant difference in TNFα/IL-10
(Table 2).
3.4.2. CultureMedium of Villous Tissue Samples. Significantly
higher levels of TNFα (P = 0.001), IL-10 (P < 0.01), and
TNF-R1 (P < 0.001) were found in the culture-conditioned
medium of abnormal karyotype group compared to the
normal karyotype group. There was no significant difference
in TNFα/IL-10 (Table 2) between the groups.
4. Discussion
The results of our study indicate that, in sporadic mis-
carriages with a normal karyotype, there is an increased
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Figure 2: Levels of cytokines in monocytes (n = 12 with normal karyotype and n = 14 with abnormal karyotype). There was no significant
difference in any of the intracellular levels of cytokines.
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Figure 3: Levels of TNF-R1 and TNF-R2 in monocytes (n = 12
with normal karyotype and n = 14 with abnormal karyotype).
There was no significant difference in any of the intracellular levels
of receptors.
maternal systemic inflammatory response with an imbalance
in the Th-1/Th-2 ratio in the maternal circulation. By
contrast, in villous samples from the same groups, we found
an increased secretion of inflammatory cytokine TNFα and
its soluble receptors, TNF-R1 and TNF-R2, and the anti-
inflammatory cytokine IL-10 in cases with an abnormal
karyotype, compared to those presenting with a normal
karyotype.
We have previously shown that in early pregnancy failure,
the excessive entry of oxygenated maternal blood into the
intervillous space has a direct mechanical effect on the villous
tissue which becomes enmeshed inside large intervillous
blood thrombi and an indirect O2-mediated trophoblastic
damage with increased apoptosis [21–23]. This phenomenon
occurs at some point in miscarriages independently of the
aetiology and in particular of the conceptus karyotype [24].
As all our villous tissue samples were obtained from missed
miscarriage, the abnormal influx of maternal oxygenated
blood would have had a similar impact on the villous tissue
of both the cases presenting with and those presenting
without a chromosomal karyotype at the time of the clinical
diagnosis. This can explain why O2and the number of days in
culture had no impact on cytokine and receptor levels in our
explant cultures experiments in both groups. The absence of
significant difference in cytokine levels in the snap frozen
samples (on day of collection) suggests that the difference
seen in culture reflects functional changes.
In the present study, we also found that in early
pregnancy (i.e., before 14 weeks), the amount of TNFα
and IL-10 secreted in vitro by villous tissue from sporadic
miscarriage was lower in the group with a normal karyotype.
These data indicate that the karyotype of the conceptus
has a direct impact on the secretion of cytokines by the
villous tissue. An abnormal karyotype leads to an elevated
local inflammatory response, confirmed by the significant
rise in TNFα. This was accompanied by a rise in the anti-
inflammatory cytokine IL-10 and the neutralizing soluble
TNF-R1 and TNF-R2. An upregulation of the cytokine
expression by the villous tissue has been reported in many
cases of unexplained spontaneous miscarriages associated
with a severe congenital infection presenting with maternal
systemic symptoms [25]. In early miscarriages, there is mas-
sive destruction of maternal immunoglobulins in embryonic
monocytes, with acute villitis in the placental barrier [26].
Some authors have therefore suggested that the upregulation
of cytokines is deleterious to the developing placenta and
fetus, probably as a consequence of vasoconstriction and/or
direct cellular damage [27, 28]. Chromosomally abnormal
spontaneous miscarriages may occur because of differ-
ent mechanisms than chromosomally normal spontaneous
miscarriages. Chromosome aberrations cause changes in
placental morphology and function, including size, shape,
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and vascularity and may affect rates of apoptosis of the
stromal cells and cell proliferation in blood vessels during
differentiation of chorionic villi [29].
In the maternal plasma, we observed inflammatory
changes in the opposite direction than in villous tissue.
The group presenting with a normal karyotype had a
shift towards a Th-1 cytokine immune response in the
circulation, reflected by a higher TNFα/IL-10 cytokine ratio
than miscarriages with abnormal karyotype. Monocytes,
in the normal karyotype group released a higher level of
TNFα upon stimulation with LPS. This suggests that in the
case of miscarriage of a karyotypically normal fetus, the
maternal systemic inflammatory response is more sensitized.
It is possible that in the case of karyotypically normal
miscarriage, there is a systemic maternal immune response
that causes the rejection of the fetus. In contrast, in cases with
an abnormal karyotype, implantation would have already
failed following the local excessive inflammatory reaction at
the materno-fetal placental interface.
In recurrent miscarriage, the circulating cytokine levels
and the decidual cytokine profile are different from those
found in normal first trimester controls [30–33]. In partic-
ular, during periconception in recurrent miscarriage, higher
circulatory levels of NK cells [34] and higher serum levels
of macrophage migration inhibition factor [35] have been
shown to be predictive of miscarriage of a conceptus with
normal karyotype. In addition, women with recurrent mis-
carriages who miscarry a pregnancy with normal karyotype
have decreased serum levels of TNFα [36] as early as 6-7
weeks of gestation. In our study, we have only looked at
spontaneous sporadic miscarriages; however, miscarriages of
normal karyotype are more likely to recur due to a possible
underlying maternal immune problem [37].
The biological functions TNFα depends on its binding
to two known receptors, TNF-R1 and TNF-R2 [38]. The
soluble forms of these membrane receptors bind to TNFα
with high affinity and can neutralize TNFα function [39,
40]. Yu et al., using flowcytometric and immunohisto-
chemical measurement of TNF-R1 in the decidua, and
detection of serum levels of soluble TNF-R1 by enzyme-
linked immunoassays, found an association between the
over-expression of TNF-R1 and early pregnancy failure [41].
In our study, villous secretion of soluble TNF-R1 in the
culture medium and soluble TNF-R2 content in villous
homogenate was significantly higher in cases presenting with
abnormal karyotype.
Our data illustrate that the mechanisms leading to a
miscarriage may depend on the karyotype of the conceptus.
We suggest that there is a local functional disturbance in the
karyotypically abnormal placental tissue while, in the case
of a normal karyotype miscarriage, rejection occurs due to
a maternal systemic inflammation.
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